Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients

[1]  Qiang Zhou,et al.  Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma , 2019, BMC Cancer.

[2]  S. Chong,et al.  Roles and Regulation of Long non-coding RNAs in Hepatocellular Carcinoma. , 2019, Cancer research.

[3]  Ling Lin,et al.  Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence , 2019, Cell Death & Disease.

[4]  Dating Sun,et al.  Integrated analyses of lncRNAs microarray profiles and mRNA–lncRNA coexpression in smooth muscle cells under hypoxic and normoxic conditions , 2019, Bioscience reports.

[5]  N. Zhang,et al.  Genome-wide identification of lncRNAs and mRNAs differentially expressed in non-functioning pituitary adenoma and construction of an lncRNA-mRNA co-expression network , 2018, Biology Open.

[6]  Nathan Lee,et al.  High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer , 2018, Front. Cell Dev. Biol..

[7]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  Lei Zheng,et al.  The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma , 2018, Molecular Cancer.

[10]  Shusen Zheng,et al.  Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma , 2018, Molecular medicine reports.

[11]  Prashant D. Tailor,et al.  Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types , 2018, Oncotarget.

[12]  H. Järveläinen,et al.  Decorin‐mediated oncosuppression – a potential future adjuvant therapy for human epithelial cancers , 2018, British journal of pharmacology.

[13]  S. Rabbani,et al.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications , 2018, Front. Oncol..

[14]  Lisha Chen,et al.  Long Non‐Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR‐143‐3p and Promotes Hepatocellular Carcinoma Progression , 2017, Journal of cellular biochemistry.

[15]  L. Ye,et al.  The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186 , 2017, The Journal of Biological Chemistry.

[16]  C. la Vecchia,et al.  Global trends and predictions in hepatocellular carcinoma mortality. , 2017, Journal of hepatology.

[17]  Yong-Jiang Xu,et al.  Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis , 2017, Oncotarget.

[18]  A. Laurinavičius,et al.  Decreased expression of MT1E is a potential biomarker of prostate cancer progression , 2017, Oncotarget.

[19]  W. Liu,et al.  The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[20]  Ram I Mahato,et al.  Recent advances in hepatocellular carcinoma therapy. , 2017, Pharmacology & therapeutics.

[21]  Jin-hua Jiang,et al.  Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression , 2017, Journal of Cancer Research and Clinical Oncology.

[22]  H. Benyamini,et al.  Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation. , 2017, Cancer research.

[23]  Lihua Jiang,et al.  Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway , 2017, BMC Cancer.

[24]  Yan Zhang,et al.  Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease , 2017, Scientific Reports.

[25]  Haiyang Xie,et al.  Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma , 2016, Carcinogenesis.

[26]  X. Liu,et al.  LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer , 2016, Scientific Reports.

[27]  R. Mitra,et al.  The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development , 2016, Molecular Cancer Therapeutics.

[28]  Jens Nielsen,et al.  Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis , 2016, Nucleic acids research.

[29]  M. Hsiao,et al.  Suppression of fructose‐bisphosphate aldolase C expression as a predictor of advanced oral squamous cell carcinoma , 2016, Head & neck.

[30]  Maria Vila-Casadesús,et al.  MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers , 2016, PloS one.

[31]  Q. Guo,et al.  Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression , 2015, Scientific Reports.

[32]  T. Järvinen,et al.  Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition , 2015, BioMed research international.

[33]  L. Ye,et al.  Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1) , 2015, Oncotarget.

[34]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[35]  Shuhan Sun,et al.  Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma , 2015, Molecular Cancer.

[36]  Edward A. Dennis,et al.  Eicosanoid storm in infection and inflammation , 2015, Nature Reviews Immunology.

[37]  B. Mitchell,et al.  Regulation of Ribosomal Gene Expression in Cancer , 2015, Journal of cellular physiology.

[38]  M. Schwartz,et al.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.

[39]  Anton J. Enright,et al.  Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing , 2015, Nature Methods.

[40]  Yu-qin Pan,et al.  Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.

[41]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[42]  X. Zhang,et al.  Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. , 2014, Cellular signalling.

[43]  Juanjuan Zhu,et al.  The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis , 2014, PloS one.

[44]  I. Kovalszky,et al.  Decorin deficiency promotes hepatic carcinogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[45]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[46]  E. Balleari,et al.  High-dose recombinant human erythropoietin for "low-risk" myelodysplastic patients: is more better? , 2013, Chinese clinical oncology.

[47]  I. Kovalszky,et al.  Decorin interferes with platelet‐derived growth factor receptor signaling in experimental hepatocarcinogenesis , 2013, The FEBS journal.

[48]  R. Pearson,et al.  Dysregulation of the basal RNA polymerase transcription apparatus in cancer , 2013, Nature Reviews Cancer.

[49]  G. Bertino.  Hepatocellular carcinoma: present and future. , 2012, Chinese clinical oncology.

[50]  Shin Jung,et al.  Role of metallothionein 1E in the migration and invasion of human glioma cell lines. , 2012, International journal of oncology.

[51]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[52]  F. Zhang,et al.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation , 2012, Medical Oncology.

[53]  Q. Wang,et al.  Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation , 2012, OncoTargets and therapy.

[54]  Xin Ma,et al.  LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray , 2012, PloS one.

[55]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[56]  J. Yun,et al.  Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis , 2012, Journal of Translational Medicine.

[57]  L. Montanaro,et al.  Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients. , 2012, Cancer research.

[58]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[59]  H. Steven Wiley,et al.  Characterization and improvement of RNA-Seq precision in quantitative transcript expression profiling , 2011, Bioinform..

[60]  Mingyao Li,et al.  RNA-sequence analysis of human B-cells. , 2011, Genome research.

[61]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[62]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[63]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[64]  L. Fajas,et al.  Metabolism and proliferation share common regulatory pathways in cancer cells , 2010, Oncogene.

[65]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[66]  V. Moreau,et al.  Rho GTPases in hepatocellular carcinoma. , 2009, Biochimica et biophysica acta.

[67]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[68]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[69]  G. Hampton,et al.  Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration , 2008, Oncogene.

[70]  Ralf Herwig,et al.  ConsensusPathDB—a database for integrating human functional interaction networks , 2008, Nucleic Acids Res..

[71]  Wancai Yang,et al.  Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. , 2008, Carcinogenesis.

[72]  J. Harrow,et al.  GENCODE: producing a reference annotation for ENCODE , 2006, Genome Biology.

[73]  L. Greenbaum.  Cell cycle regulation and hepatocarcinogenesis , 2004, Cancer biology & therapy.

[74]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[75]  B. Calabretta,et al.  Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  C. Lazure,et al.  Prostatic kallikrein hK2, but not prostate‐specific antigen (hK3), activates single‐chain urokinase‐type plasminogen activator , 1997, International journal of cancer.

[77]  S. Fan,et al.  Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases , 1992, Cancer.

[78]  M. Salit,et al.  Synthetic Spike-in Standards for Rna-seq Experiments Material Supplemental Open Access License Commons Creative , 2022 .